GLP-1 therapy boosts visceral fat metabolism, driving weight loss

Researchers discuss the role of enhanced visceral adipose tissue metabolism in mediating weight loss by glucagon-like peptide-1 drugs.

Teladoc Health Announces Executive Leadership Change

Laizer Kornwasser, President of Enterprise Growth and Global Markets What You Should Know: – Teladoc Health, Inc. has announced a significant change in its executive

July 8, 2024

Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection

What You Should Know: – Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.

January 10, 2024

Next-in-Class Once-Daily Pill Approved for Cystic Fibrosis

The FDA approved a once-daily oral combination of vanzacaftor/tezacaftor/deutivacaftor (Alyftrek) for cystic fibrosis (CF) in adults and children 6 years and up, drugmaker Vertex Pharmaceuticals

December 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.